
    
      The study was an single dose, two-way, crossover, oral bioequivalence study of Lamotrigine
      tablets 200 mg of Dr. Reddy's Laboratories Limited, India comparing with that of LAMICTALÂ®
      tablets 200 mg of GlaxoSmithKline Inc, in healthy, adult, human subjects under fed condition.
      20 subjects (14 male and 6 womens) are enrolled and completed the study. The washout period
      is 14 days between the two periods of the study.
    
  